21 results · 25ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Taperloc® Complete Hip Stems

FDA 510(k)
FDA Class 2 ·Orthopedic

LCP

FDA UDI
Synthes GmbH·10886982141224·1.8MM LCP BUTTRESS PIN 24MM

K-Wire Sleeve

FDA UDI
Treace Medical Concepts, Inc.·00810111222754·K-Wire Sleeve

MICRO FORCEPS

FDA UDI
SONTEC INSTRUMENTS, INC.·00192896060449·MICRO FORCEPS WITH PLATFORM CURVED TUNGSTEN CAR...

Millennium

FDA UDI
Avalign Technologies, Inc.·00190776165468·DEAVER RETRACTOR

Initia Total Hip System

FDA UDI
KYOCERA CORPORATION·04547898307942·MXHO LINER 40-72/74

MeDiCa

FDA UDI
SCIMEDX CORPORATION·00813545026936·A-nDNA-A Crithidia luciliae 96 Test Kit

Integra® Jarit®

FDA UDI
INTEGRA LIFESCIENCES PRODUCTION CORPORATION·10381780024811·Integra® Jarit® Deaver Retractor, 6-3/4", Doubl...

FREESTYLE

FDA Adverse Event
Injury ·THERASENSE, INC.·Product code LFR·July 31, 2003

MODIFICATION TO SILHOUETTE SPINAL FIXATION SYSTEM

FDA 510(k)
FDA Class 2 ·Orthopedic

ACCESS MYOGLOBIN ON THE ACCESS IMMUNOASSAY ANALYZER, MODELS 33310, 33315, 33319, 33316

FDA 510(k)
FDA Class 2 ·Immunology

FREESTYLE LIBRE 2 PLUS

FDA Adverse Event
Malfunction ·ABBOTT DIABETES CARE INC·Product code QBJ·May 20, 2026

CPR-D PADZ

FDA Adverse Event
Death ·BIO-DETEK INCORPORATED·Product code MKJ·January 17, 2025

LIFECARE PCA PLUS INFUSER

FDA Adverse Event
Other ·HOSPIRA, INC.·Product code MEA·October 6, 2008

COLLEAGUE PRE P1.7

FDA Adverse Event
Malfunction ·BAXTER HEALTHCARE - SINGAPORE·Product code FRN·August 11, 2011

SYNCHROMED II

FDA Adverse Event
Injury ·MDT PUERTO RICO OPERATIONS CO·Product code LKK·July 1, 2013

SMR SHOULDER

FDA Adverse Event
Injury ·LIMACORPORATE S.P.A.·Product code MBF·December 7, 2023

SMR SHOULDER

FDA Adverse Event
Injury ·LIMACORPORATE S.P.A.·Product code KWS·March 3, 2025

St. Jude Medical CONFIRM Rx Insertable Cardiac Monitor, Sterile EO, Model #: DM3500 The Confirm Rx ICM is indicated for the monitoring and diagnostic evaluation of patients who experience unexplained symptoms such as: dizziness, palpitations, chest pain, syncope, and shortness of breath, as well as patients who are at risk for cardiac arrhythmias. It is also indicated for patients who have been previously diagnosed with atrial fibrillation or who are susceptible to developing atrial fibrillation.

FDA Enforcement
Class II ·Terminated·St Jude Medical Inc.·July 11, 2018

dS Breast 7ch 1.5T

FDA Enforcement
Class II ·Ongoing·Philips North America Llc·December 4, 2024